Jazz Pharmaceuticals Plc

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IE00B4Q5ZN47
USD
256.56
-0.09 (-0.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,208.30
1,068.90
1,197.93
1,126.11
1,045.71
897.84
1,088.17
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,208.30
1,068.90
1,197.93
1,126.11
1,045.71
897.84
1,088.17
Raw Material Cost
286.40
306.40
323.27
297.25
278.37
259.07
287.62
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
62.40
63.30
65.81
66.77
66.06
80.91
82.20
Selling and Distribution Expenses
389.20
352.70
406.21
469.15
358.40
514.01
369.29
Other Expenses
14.51
13.27
14.81
13.14
12.39
9.97
15.83
Total Expenditure (Excl Depreciation)
883.10
855.10
943.39
964.60
826.74
953.73
897.40
Operating Profit (PBDIT) excl Other Income
325.20000000000005
213.79999999999998
254.5
161.5
219
-55.9
190.79999999999998
Other Income
26.30
157.20
21.86
25.11
4.50
18.38
48.58
Operating Profit (PBDIT)
530.60
552.40
455.56
364.87
397.48
127.36
407.77
Interest
62.40
63.30
65.81
66.77
66.06
80.91
82.20
Exceptional Items
-78.10
-8.50
-2.11
-110.82
-892.97
8.61
-23.93
Gross Profit (PBDT)
921.90
762.50
874.66
828.86
767.34
638.77
800.56
Depreciation
179.10
181.40
179.17
178.25
174.01
164.87
168.42
Profit Before Tax
211.00
299.20
208.47
9.04
-735.55
-109.81
133.22
Tax
18.10
6.10
4.96
-242.42
-17.17
-17.81
-57.91
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
192.80
293.10
203.45
251.41
-718.47
-92.54
191.12
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
192.80
293.10
203.45
251.41
-718.47
-92.54
191.12
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
192.80
293.10
203.45
251.41
-718.47
-92.54
191.12
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
4,801.70
4,532.30
4,318.58
3,959.03
3,706.36
4,174.89
4,093.76
Earnings per share (EPS)
2.78
4.43
3.21
4.08
-11.74
-1.52
3.11
Diluted Earnings per share
2.78
4.43
3.21
4.08
-11.74
-1.52
3.11
Operating Profit Margin (Excl OI)
26.91%
20.0%
21.25%
14.34%
20.94%
-6.23%
17.53%
Gross Profit Margin
32.29%
44.96%
32.36%
16.63%
-53.7%
6.13%
27.72%
PAT Margin
15.96%
27.42%
16.98%
22.33%
-68.71%
-10.31%
17.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 15.55% vs 2.14% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 126.83% vs -526.16% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 28.32% vs 8.41% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is -5.60% vs -23.23% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Compare Quarterly Results Of Jazz Pharmaceuticals Plc With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,208.30
2.52
1,205.78
47,848.41%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,208.30
2.52
1,205.78
47,848.41%
Raw Material Cost
286.40
0.96
285.44
29,733.33%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
62.40
0.00
62.40
Selling and Distribution Expenses
389.20
157.61
231.59
146.94%
Other Expenses
14.51
19.89
-5.38
-27.05%
Total Expenditure (Excl Depreciation)
883.10
357.52
525.58
147.01%
Operating Profit (PBDIT) excl Other Income
325.20
-355.00
680.20
191.61%
Other Income
26.30
64.78
-38.48
-59.40%
Operating Profit (PBDIT)
530.60
-289.58
820.18
283.23%
Interest
62.40
0.00
62.40
Exceptional Items
-78.10
744.31
-822.41
-110.49%
Gross Profit (PBDT)
921.90
1.56
920.34
58,996.15%
Depreciation
179.10
0.64
178.46
27,884.38%
Profit Before Tax
211.00
454.10
-243.10
-53.53%
Tax
18.10
98.35
-80.25
-81.60%
Provisions and contingencies
0
0
0.00
Profit After Tax
192.80
302.99
-110.19
-36.37%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
192.80
302.99
-110.19
-36.37%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
52.75
-52.75
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
192.80
355.74
-162.94
-45.80%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
4,801.70
4,527.37
274.33
6.06%
Earnings per share (EPS)
2.78
0.37
2.41
651.35%
Diluted Earnings per share
2.78
0.37
2.41
651.35%
Operating Profit Margin (Excl OI)
26.91%
-14,087.10%
0.00
14,114.01%
Gross Profit Margin
32.29%
18,045.04%
0.00
-18,012.75%
PAT Margin
15.96%
12,023.57%
0.00
-12,007.61%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 120.83 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 13.04% vs -10.77% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 15.55% vs 2.14% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 19.28 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -34.22% vs 44.03% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 126.83% vs -526.16% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 50.43 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 27.61% vs -8.88% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 28.32% vs 8.41% in Jun 2025

Quarterly - Interest
Interest 6.24 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -1.42% vs -3.80% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -5.60% vs -23.23% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.91%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025